Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V-RBAC in High-risk Elderly Patients With Mantle Cell Lymphoma
NCT03567876Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Sep 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in mantle cell lymphoma (MCL), sponsored by Fondazione Italiana Linfomi. Started Sep 2018; status: completed.
02
Drugs
venetoclax
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT03567876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03567876.